Key facts
- It has raised $440K across 1 recorded rounds; the latest was Seed Round ($440K) in Jun 2025.
- Notable investors include CancerX (USA).
- MyCareGorithm has filed 1 Form D with the SEC, most recently Aug 2025 ($440K sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MyCareGorithm
Funding rounds
1 roundsAbout MyCareGorithm
Developer of digital healthcare consultation tools designed to support oncology professionals and patients in clinical encounters. The company's platform presents interactive visualisations, personalised multimedia content, structured educational modules tailored to specific cancer diagnoses and treatment options, and shareable summaries for use during and after consultations, enabling oncology practices and healthcare institutions to improve patient comprehension, support informed decision making, and reduce misunderstanding and anxiety in complex treatment discussions.
- Sector
- Healthcare
- HQ
- Watchung, NJ, United States
- Founded
- 2021
- Employees
- 12
- Website
- mycaregorithm.com/
- Ownership
- Privately Held (backing)
MyCareGorithm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MyCareGorithm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MyCareGorithm in its N-PORT filings yet. We sweep new filings monthly.